Uncategorized

Soliton_PIPE_9.5_Million

Posted in Recent Developments, Recent Transactions, Sector: Healthcare, Type: PIPEs & Private Placements, Uncategorized | Comments Off

New Data From the Phase 1/2 NEWTON Study of Edge Therapeutics’ EG-1962 to bePresented at the International Stroke Conference 2016

BERKELEY HEIGHTS, N.J., Feb. 10, 2016 (GLOBE NEWSWIRE) — Edge Therapeutics, Inc. (EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions, today announced that the full dataset from its North American Phase 1/2 … Continue reading

Posted in Recent Developments, Uncategorized | Comments Off

NeuroMetrix Closes $14.7 Million Public Offering

WALTHAM, Mass.–(BUSINESS WIRE)– NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it has closed its previously announced underwritten public offering. The Company sold 147,000 units, with each unit consisting of one share of Series B convertible preferred stock and 99 warrants exercisable for … Continue reading

Posted in Uncategorized | Comments Off

Applied DNA Sciences Prices $11.5 Million Public Offering

STONY BROOK, NY, – Applied DNA Sciences, Inc. (NASDAQ: Common Stock-APDN, Warrants-APDNW) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, supply chain and product authentication solutions, announced that it has priced its previously announced underwritten public offering of 3,820,000 shares … Continue reading

Posted in Uncategorized | Comments Off

Oxford Lane Capital Corp. Prices Preferred Stock Offering

GREENWICH, CT–(Marketwired – May 29, 2014) – Oxford Lane Capital Corp. (the “Company”) (NASDAQ: OXLC) (NASDAQ: OXLCP) (NASDAQ: OXLCO) today announced that it has priced an underwritten public offering of 1,120,000 shares of its newly designated 8.125% Series 2024 Term … Continue reading

Posted in Uncategorized | Comments Off

Benitec Announces Pricing Of An Initial Public Offering In The United States With Listing On NASDAQ

SYDNEY, Aug. 18, 2015 /PRNewswire/ — Benitec Biopharma Limited (NASDAQ: BNTC; NASDAQ: BNTCW; ASX: BLT), a clinical-stage biotechnology company, is pleased to announce the pricing of its U.S. initial public offering of 1,500,000 American Depositary Shares[1] (ADSs), representing 30,000,000 fully … Continue reading

Posted in Uncategorized | Comments Off

Intec Pharma Ltd. Announces Closing of U.S. Initial Public Offering

Har Hotzvim, Jerusalem, Israel, August 7, 2015 – Intec Pharma Ltd. (the “Company”) (NASDAQ: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced the closing of its previously announced … Continue reading

Posted in Uncategorized | Comments Off

Perseon Corporation Announces Pricing of $5.2 Million Public Offering and Listing of Warrants on NASDAQ

July 30, 2015 – SALT LAKE CITY, (GLOBE NEWSWIRE) — Perseon Corporation (NASDAQ:PRSN) (NASDAQ:PRSNW) (“Perseon” or the “Company”), a leading provider of medical systems that utilize energy to treat cancer, today announced the pricing of an underwritten public offering of … Continue reading

Posted in Uncategorized | Comments Off

Trovagene, Inc. Announces Closing of Public Offering of Common Stock

July 22, 2015 – SAN DIEGO /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV) today announced the closing of its previously announced underwritten public offering.  The Company sold 4,600,000 shares of its common stock in the offering, which includes 600,000 shares that … Continue reading

Posted in Uncategorized | Comments Off

Wheeler Real Estate Investment Trust, Inc. Announces Final Tender Results of Exchange Offer for Series A Preferred Stock and Series B Convertible Preferred Stock

July 21, 2015 – VIRGINIA BEACH, Va.– Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) (“Wheeler” or the “Company”) today announced the results of its offer to exchange all outstanding shares of the Company’s Series A Preferred Stock, without par value … Continue reading

Posted in Uncategorized | Comments Off

Provectus Biopharmaceuticals, Inc. Announces Pricing of Public Offering to Raise $13.1 Million

June 19, 2015 – KNOXVILLE, Tenn.–(BUSINESS WIRE)–Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”), today announced the pricing of an underwritten public offering of 17,500,000 shares of common stock and … Continue reading

Posted in Uncategorized | Comments Off

Oxford Lane Capital Corp. Prices Preferred Stock Offering

June 18, 2015 – GREENWICH, CT — (Marketwired)  – Oxford Lane Capital Corp. (the “Company”) (NASDAQ: OXLC) (NASDAQ: OXLCP) (NASDAQ: OXLCO) (NASDAQ: OXLCN) today announced that it has priced an underwritten public offering of 1,224,490 shares of its 7.50% Series … Continue reading

Posted in Uncategorized | Comments Off

Rock Creek Pharmaceuticals, Inc. Announces $3.7 Million Registered Direct Offering

June 17, 2015 – SARASOTA, Fla., /PRNewswire/ — Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI) (Rock Creek), a drug development company focused on chronic inflammatory disorders, announced today that it has entered into definitive agreements with institutional investors to raise approximately $3.7 … Continue reading

Posted in Uncategorized | Comments Off

Genetic Technologies

Posted in Uncategorized | Comments Off

Remark Media Announces $3.4 Million Registered Direct Offering

LAS VEGAS, March 30, 2015 /PRNewswire/ — Remark Media, Inc. (NASDAQ: MARK) (“Remark Media” or the “Company”) today announced that it has entered into subscription agreements with various investors for the sale of its common stock in a registered direct offering. … Continue reading

Posted in Uncategorized | Comments Off

Wheeler Real Estate Investment Trust, Inc. Completes Offering and Sale of $90 Million of Series C Convertible Preferred Stock

VIRGINIA BEACH, Va.– Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) (“Wheeler” or the “Company”) announced today that the Company has entered into definitive purchase agreements with accredited investors in a private placement transaction that resulted in gross proceeds of $90 … Continue reading

Posted in Uncategorized | Comments Off

ADMA Biologics Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full

RAMSEY, N.J., March 18, 2015 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced today the closing of … Continue reading

Posted in Uncategorized | Comments Off

Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants

PORTLAND, Ore., March 18, 2015 (GLOBE NEWSWIRE) — Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the closing of its … Continue reading

Posted in Uncategorized | Comments Off

Arlington Asset Investment Corp. Announces Closing of Senior Notes Offering

ARLINGTON, Va., March 18, 2015 /PRNewswire/ — Arlington Asset Investment Corp. (NYSE: AI) (the “Company”) announced today that it has closed an underwritten registered public offering of $35,300,000 aggregate principal amount of 6.75% Senior Notes due 2025 (the “Notes”), which … Continue reading

Posted in Uncategorized | Comments Off

Gladstone Investment Corporation Prices Common Stock Offering

MCLEAN, Va., March 10, 2015 (GLOBE NEWSWIRE) — Gladstone Investment Corporation (Nasdaq:GAIN) (the “Company”) today announced that it has entered into an agreement to sell 3,300,000 shares of its common stock at a public offering price of $7.40 per share, … Continue reading

Posted in Uncategorized | Comments Off

BioLineRx Prices $25 Million Underwritten Public Offering of its American Depositary Shares

Jerusalem, Israel, March 6, 2015 – BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today announced that it has priced an underwritten public offering of 12,500,000 American Depositary Shares (“ADSs”), … Continue reading

Posted in Uncategorized | Comments Off

Genetic Technologies Announces AUD$18.6 Million Capital Raising

Melbourne, Australia; 6 March 2015: Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”) Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”) is pleased to announce that it has raised approximately AUD$18.6 million at a weighted average issue price of AUD$0.0372 … Continue reading

Posted in Uncategorized | Comments Off

NovaBay Announces $4.9 Million Private Placement

EMERYVILLE, CA – March 4, 2015 NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company developing and commercializing non-antibiotic anti-infective products focused on the global eye care market,(“NovaBay”), today announced that it has entered into a securities purchase agreement for … Continue reading

Posted in Uncategorized | Comments Off

Check-Cap Announces Closing of Initial Public Offering and Simultaneous Private Placement

ISFIYA, Israel, Feb. 25, 2015 /PRNewswire/ — Check-Cap Ltd., (Nasdaq: CHEKU) a clinical stage medical diagnostics company engaged in the development of a preparation-free ingestible imaging capsule that utilizes low-dose X-rays for the screening for colorectal cancer, announced today the … Continue reading

Posted in Uncategorized | Comments Off

GeoVax Announces Equity Financing of Up to $6 Million

GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel platform technology, today announced that it has entered into a definitive agreement to sell up to $6 million of its equity securities to a single … Continue reading

Posted in Uncategorized | Comments Off

Keryx (Featured Transaction Homepage slider)

Posted in Uncategorized | Comments Off

Omeros 84 mil (Featured Transaction Homepage slider)

Posted in Uncategorized | Comments Off

Keryx Featured Transaction

Posted in Uncategorized | Comments Off

Omeros Featured Transaction

Posted in Uncategorized | Comments Off

Galmed (Featured Transaction Homepage slider

Posted in Uncategorized | Comments Off

capnia (featured transaction-homepage slider)

Posted in Uncategorized | Comments Off

Keryx (Featured Transaction/Homepage sliders)

Posted in Uncategorized | Comments Off

Omeros (Featured Transactions/Homepage sliders)

Posted in Uncategorized | Comments Off

Trovagene, Inc. Announces Closing of Public Offering of Common Stock

SAN DIEGO, Feb. 11, 2015 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV) today announced the closing of its previously announced underwritten public offering. The Company sold 5,111,110 shares of its common stock in the offering, which includes 666,666 shares that were … Continue reading

Posted in Uncategorized | Comments Off

Omeros Closes $84 Million Public Offering of Common Stock and Pre-Funded Warrants

SEATTLE, Feb. 3, 2015 /PRNewswire/ — Omeros Corporation (NASDAQ: OMER) today announced that it has closed the underwritten public offering that was priced and allocated to investors on January 28, 2015 relating to the sale of 3,444,831 shares of its … Continue reading

Posted in Uncategorized | Comments Off

ZIOPHARM Oncology Announces Pricing of Public Offering of Common Stock

BOSTON, Feb. 3, 2015 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that it has priced its previously announced underwritten public offering of common stock consisting of 10,000,000 shares at a public offering price of $8.75 per share. Gross … Continue reading

Posted in Uncategorized | Comments Off

Capnia (Featured Transaction/Homepage sliders)

Posted in Uncategorized | Comments Off

Auspex Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

LA JOLLA, Calif., Jan. 28, 2015 (GLOBE NEWSWIRE) — Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a biopharmaceutical company dedicated to developing innovative medicines for people with movement disorders and other rare diseases, today announced the closing of its previously announced underwritten public … Continue reading

Posted in Uncategorized | Comments Off

Oculus Innovative Sciences Announces Closing of $6.3 Million Underwritten Public Offering

PETALUMA, Calif., Jan. 26, 2015 (GLOBE NEWSWIRE) — Oculus Innovative Sciences, Inc. (Nasdaq: Common Stock – OCLS, Warrants – OCLSW) today announced the closing of its previously announced underwritten public offering of 6,250,000 shares of common stock, and warrants to … Continue reading

Posted in Uncategorized | Comments Off

Profire (Featured Transactions / Homepage sliders)

Posted in Uncategorized | Comments Off

KERYX BIOPHARMACEUTICALS, INC. ANNOUNCES PRICING OF $110 MILLION PUBLIC OFFERING OF COMMON STOCK

NEW YORK, Jan. 21, 2015 (GLOBE NEWSWIRE) — Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the pricing of an underwritten public offering of common stock consisting of 9,166,667 shares at $12.00 per share, for gross proceeds of $110 million. In connection … Continue reading

Posted in Uncategorized | Comments Off

Anworth Announces Pricing of Public Offering of Its 7.625% Series C Preferred Stock

SANTA MONICA, Calif.–(BUSINESS WIRE)– Anworth Mortgage Asset Corporation (NYSE: ANH) (the “Company”) announced today that it has priced an underwritten public offering of 300,000 shares of its 7.625% Series C Cumulative Redeemable Preferred Stock (“Series C Preferred Stock”) at a … Continue reading

Posted in Uncategorized | Comments Off

Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full

SAN DIEGO, CA — (January 14, 2015) – Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease, allergy, oncology and immunology, announced today the closing of its … Continue reading

Posted in Uncategorized | Comments Off

BrainStorm Enters Into Warrant Exercise Agreement for Approximately $13 Million in Proceeds Warrant Holders Exercising at a Premium; to Receive New Warrants

Hackensack, NJ & Petach Tikvah, Israel – January 8, 2015 – BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced it has entered into a Warrant Exercise Agreement with certain holders … Continue reading

Posted in Uncategorized | Comments Off

Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering

SAN DIEGO, Sept. 29, 2014 /PRNewswire/ — Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, announced today the closing of its previously announced $12.5 million registered direct offering. As previously disclosed, Lpath sold 3,605,042 registered shares of … Continue reading

Posted in Uncategorized | Comments Off

Quest Resource Holding Corporation Closes $18.0 Million Underwritten Public Offering of Common Stock and Warrants

FRISCO, TX — (Marketwired) — 09/24/14 — Quest Resource Holding Corporation (NASDAQ: QRHC) announced today the closing of its previously announced $18.0 million underwritten public offering, consisting of 9,000,000 shares of common stock at a price per share of $1.99, … Continue reading

Posted in Uncategorized | Comments Off

Gladstone Land Corporation Announces Pricing of Common Stock Offering

MCLEAN, Va., Sept. 24, 2014 (GLOBE NEWSWIRE) — Gladstone Land Corporation (Nasdaq:LAND) (the “Company”) today announced that it has priced its public offering of 1,150,000 shares of its common stock at a price to the public of $12.28 per share. … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group acted as co-manager on Immunovaccine’s $8.7 million follow-on offering

Halifax, Nova Scotia; September 4, 2014 – Immunovaccine Inc. (“Immunovaccine”, “IMV”, or the “Company”) (TSX-V: IMV), a clinical stage vaccine and immunotherapy company, has closed the previously announced public offering (the “Offering”), raising gross proceeds of $9,514,543. Under the terms … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group acted as joint book-running manager on Miller Energy Resources’ $17.1 million preferred stock offering

KNOXVILLE, TN — (Marketwired) — 08/26/14 — Miller Energy Resources, Inc. (NYSE: MILL) (the “Company”) announced today that, on August 25, 2014, it completed and closed its previously announced underwritten public offering of its 10.5% Series D Fixed Rate/Floating Rate … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group acted as senior co-manager on Fifth Street Senior Floating Rate Corp.’s  $294.3 million follow-on offering

GREENWICH, CT, Aug. 19, 2014 (GLOBE NEWSWIRE) — Fifth Street Senior Floating Rate Corp. (NASDAQ:FSFR) (“FSFR”) today announced that it has closed a public offering of 22,800,000 shares of its common stock at a public offering price of $12.91 per … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group acted as co-manager on Paragon Shipping Inc.’s $25.0 million follow-on offering

ATHENS, Greece (August 5, 2014) – Paragon Shipping Inc. (NASDAQ:PRGN) (“Paragon Shipping” or the “Company”) announced today that it has priced its previously announced public offering of senior unsecured notes due 2021 (the “Notes”). The Notes will bear interest at … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group acted as sole book-running manager on Contrafect Corporation’s $36.0 million initial public offering

YONKERS, NY — (Marketwired) — 08/04/14 — ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, announced today that on August 1, 2014 it closed its initial public offering of 6,000,000 … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group acted as co-manager on FX Energy Inc.’s $20.0 million preferred stock offering

Salt Lake City, July 17, 2014 – FX Energy, Inc. (NASDAQ: FXEN) (the “Company”) announced today that it has closed its underwritten public offering of 800,000 shares of its 9.25% Series B Cumulative Convertible Preferred Stock (the “Series B Preferred … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as sole placement agent for RestorGenex Corporation’s $35.6 million private placement.

RestorGenex Corporation (RESX), a specialty biopharmaceutical company, announced today that it closed its private placement, which raised approximately $35.6 million in gross proceeds. RestorGenex received net proceeds of approximately $31.3 million, after deducting placement agent fees and other offering expenses. … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-placement agent in RGS Energy’s $7.0 million private placement.

LOUISVILLE, Colo., July 3, 2014 (GLOBE NEWSWIRE) — RGS Energy (RGSE) has entered into a definitive agreement to raise approximately $7.0 million in a private placement financing transaction. Under the terms of the agreement, RGS Energy will issue units consisting … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as joint book-running manager for Profire Energy, Inc.’s $24.0 million follow-on offering.

LINDON, Utah, June 27, 2014 (GLOBE NEWSWIRE) — Profire Energy, Inc. (PFIE) today announced the pricing of a $24,000,000 underwritten public offering of 6,000,000 shares of its common stock, at a price of $4.00 per share. 4,500,000 of the shares … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as sole placement agent for BSD Medical Corporation’s $5.2 million registered direct offering.

SALT LAKE CITY–(BUSINESS WIRE)–BSD Medical Corporation (NASDAQCM: BSDM) (BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that it has entered into definitive agreements with institutional investors to raise approximately $5,225,000 in a registered … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as sole book-running manager for RiceBran Technologies $7.5 million follow-on offering.

SCOTTSDALE, Ariz., June 20, 2014 /PRNewswire/ – RiceBran Technologies (RIBT)(the “Company”) today announced the pricing of an underwritten public offering  of 1,417,500 shares of the Company’s common stock priced at $5.29 per share and warrants to purchase 708,750 shares of the Company’s … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as sole book-running manager for Cesca Therapeutics Inc.’s $11.3 million follow-on offering.

RANCHO CORDOVA, Calif., June 13, 2014 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (KOOL), an autologous cell-based regenerative medicine company, announced today the pricing of an underwritten public offering of 7,530,000 Units, consisting of an aggregate of 7,530,000 shares of the … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as sole placement agent for BrainStorm Cell Therapeutics Inc.’s $10.5 million private placement.

NEW YORK, NY and PETAH TIKVA, ISRAEL–(Marketwired – Jun 13, 2014) – BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), an innovative developer of adult stem cell technologies and Central Nervous System therapeutics, today announced that it has entered into definitive agreements with … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-manager for RCS Capital Corp.’s $486.0 million follow-on offering.

NEW YORK, June 5, 2014 /PRNewswire/ — RCS Capital Corporation (NYSE: RCAP) (“RCAP”) announced today that it has priced its previously announced public offering.  Pursuant to the offering, RCAP is offering $384.8 million of its Class A Common Stock, and RCAP Holdings, … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-manager for Oxford Lane Capital’s $28.0 million preferred stock offering.

GREENWICH, CT — (Marketwired) — 05/29/14 — Oxford Lane Capital Corp. (the “Company”) (NASDAQ: OXLC) (NASDAQ: OXLCP) (NASDAQ: OXLCO) today announced that it has priced an underwritten public offering of 1,120,000 shares of its newly designated 8.125% Series 2024 Term … Continue reading

Posted in Uncategorized | Comments Off

America Capital Mortgage Follow-on 175.0MM

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-manager for American Capital Mortgage Investment Corp.’s $50.0 million preferred stock offering.

BETHESDA, Md., May 15, 2014 /PRNewswire/ — American Capital Mortgage Investment Corp. (MTGE) (“MTGE” or the “Company”) announced today that it has priced a public offering of 2 million shares of its 8.125% Series A Cumulative Redeemable Preferred Stock, liquidation preference of … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-manager for Gladstone Capital Corporation’s $55.0 million preferred stock offering.

MCLEAN, Va., May 14, 2014 (GLOBE NEWSWIRE) — Gladstone Capital Corporation (GLAD) (the “Company”) today announced that it has entered into an agreement to sell 2,200,000 shares of its newly designated 6.75% Series 2021 Term Preferred Shares (the “Series 2021 Term Preferred … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-manager for American Capital Agency Corp.’s $175.0 follow-on-offering.

BETHESDA, Md., May 5, 2014 /PRNewswire/ — American Capital Agency Corp. (AGNC) (“AGNC” or the “Company”) announced today that it has priced a public offering of 7 million depositary shares with a liquidation preference of $25.00 per share (the “Depositary Shares”), for … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as joint book-running manager for Wheeler Real Estate Investment Trust, Inc.’s $18 million preferred stock offering.

Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) (“Wheeler” or the “Company”), a company specializing in owning, acquiring, financing, developing, renovating, leasing and managing income producing assets, such as community centers, neighborhood centers, strip centers and free-standing retail properties, has completed … Continue reading

Posted in Uncategorized | Comments Off

Contrafect (Featured Transactions/ Homepage sliders)

Posted in Uncategorized | Tagged , | Comments Off

Wheeler (Featured Transactions/ Homepage sliders)

Posted in Uncategorized | Tagged , , | Comments Off

Galmed Pharmaceuticals (Featured Transactions/ Homepage sliders)

Posted in Uncategorized | Tagged , , | Comments Off

Paragon Shipping (Featured Transactions/ Homepage sliders)

Posted in Uncategorized | Tagged , | Comments Off

Maxim Group LLC served as co-manager for Arlington Asset Investment Corp.’s $81.7 million follow-on offering.

Arlington Asset Investment Corp. (NYSE: AI) (the “Company”) announced today that it has completed its previously-announced public offering of 3,062,500 shares of Class A common stock including 312,500 shares of Class A common stock issued pursuant to the partial exercise … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC served as co-manager for Seaspan Corporation’s $300 million fixed income offering.

Seaspan Corporation (“Seaspan”) (NYSE:SSW) announced today that it has priced its previously announced $300 million public offering of senior unsecured notes due 2019 (the “Notes”). The Notes will mature on April 30, 2019 and will bear interest at a rate … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as sole placement agent for IsoRay, Inc.’s $14.7 million registered direct offering.

IsoRay, Inc. (NYSE MKT:ISR) announced today that it closed on a $14,675,180 registered direct placement (the “Offering”) of 5,644,300 shares of common stock at a price of $2.60 per share with two institutional investors yesterday. IsoRay intends to use the … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-manager for Orchid Island Capital, Inc.’s $40.2 million registered direct offering.

Orchid Island Capital, Inc. (the “Company”) (NYSE MKT:ORC) announced today the pricing of its public offering of 3,200,000 shares of common stock at $12.55 per share. The offering is expected to close on March 24, 2014. The Company has granted … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as sole placement agent for Avanex Life Sciences Corp.’s $10 million convertible note offering.

Anavex Life Sciences Corp. (“Anavex” or the “Company”)(OTCQB:AVXL), a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s, diseases of the central nervous system (CNS) and various types of cancer, announced today that it has closed, as previously … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC served as sole book-running manager for Galmed Pharmaceuticals, Inc.’s $44.1 million initial public offering.

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed”) today announced the closing of its initial public offering of 3,263,010 ordinary shares at a public offering price of $13.50 per share, which included 425,610 ordinary shares issued upon the exercise in full of … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-manager for Omeros Corporation’s $35 million follow-on offering.

Omeros Corporation (NASDAQ: OMER) today announced that it has priced an underwritten public offering of 3,043,479 shares of its common stock at a price to the public of $11.50 per share for gross proceeds of $35.0 million. The net proceeds … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-manager for BiolineRx Ltd.’s $24.1 million follow-on offering.

BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today announced that it has closed its previously announced underwritten public offering of 9,660,000 American Depositary Shares (“ADSs”), each representing ten (10) … Continue reading

Posted in Uncategorized | Comments Off

Maxim Group LLC acted as co-manager for Magic Software Enterprises Ltd. $51 million follow-on offering.

Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC) (the “Company”), a global provider of mobile and cloud-enabled application development and business integration platforms, announced today the closing of its previously announced public offering of 6,900,000 ordinary shares, including 900,000 shares … Continue reading

Posted in Uncategorized | Comments Off

UBIC, Inc. Completes Matters Regarding UBIC’s Acquisition of Shares of EvD, Inc.

NEW YORK, Aug. 3, 2015 (GLOBE NEWSWIRE) — UBIC, Inc. (Nasdaq:UBIC) (TSE:2158) (“UBIC” or “the Company”), a leading provider of international litigation support and big-data analysis services, announced today that at the board of directors meeting held on July 31, … Continue reading

Posted in Uncategorized | Comments Off

Wan Air_Strategic Advisory

Posted in Uncategorized | Comments Off

HYKI_Strategic Advisory

Posted in Uncategorized | Comments Off